Drug Profile
Research programme: protein therapeutics - Anaphore
Alternative Names: Atrimer; Atrimer drug conjugates; Atrimers; ATX-3105; IL-23R - Anaphore; MBP-DC-SIGN; Trail-R - AnaphoreLatest Information Update: 24 Aug 2023
Price :
$50
*
At a glance
- Originator Borean Pharma
- Developer Bird Rock Bio
- Class Proteins
- Mechanism of Action Apoptosis stimulants; Interleukin 23 inhibitors; TRAIL receptor 1 agonists; TRAIL receptor 2 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Autoimmune disorders; Cancer; Psoriasis
Highest Development Phases
- No development reported Autoimmune disorders; Cancer; Psoriasis
Most Recent Events
- 21 Aug 2023 Bird Rock Bio has been acquired by Skye Bioscience
- 04 Nov 2017 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (Parenteral)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)